Purple Biotech (PPBT) Current Leases (2019 - 2026)
Purple Biotech's (PPBT) quarterly Current Leases came in at $184000.0 in Q1 2026, up 34.31% year-on-year from $137000.0 in Q1 2025, and down 24.59% on a QoQ basis from $244000.0 in Q4 2025.
Purple Biotech (PPBT) Current Leases (2019 - 2026) Analysis & Trends
Purple Biotech (PPBT) has 8 years of Current Leases data on file, last reported at $184000.0 in Q1 2026.
- On a quarterly basis, Current Leases rose 34.31% year-over-year to $184000.0 in Q1 2026; TTM through Mar 2026 was $184000.0, a 34.31% increase from a year earlier, with the FY2025 full-year figure at $244000.0, up 33.33% from the prior year.
- Current Leases for Q1 2026 stood at $184000.0, down from $244000.0 in the prior quarter.
- Over the last five years, Current Leases for PPBT reached as high as $244000.0 in Q4 2025 and fell as low as $103000.0 in Q2 2025.
- Historically, Current Leases has averaged $184117.6 across 5 years, with a median of $186000.0 in 2024.
- Across the five-year window, Current Leases sank 43.41% in 2025 and jumped 34.31% in 2026, its largest moves.
- Year by year, Current Leases stood at $194000.0 in 2022, then slipped by 3.09% to $188000.0 in 2023, then declined by 2.66% to $183000.0 in 2024, then soared by 33.33% to $244000.0 in 2025, then retreated by 24.59% to $184000.0 in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $184000.0 in Q1 2026, $244000.0 in Q4 2025, and $207000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Purple Biotech | 1.33 Bn | 1.33 Bn | - | 184,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 184,000.00 |
| Dec 31, 2025 | 244,000.00 |
| Sep 30, 2025 | 207,000.00 |
| Jun 30, 2025 | 103,000.00 |
| Mar 31, 2025 | 137,000.00 |
| Dec 31, 2024 | 183,000.00 |
| Sep 30, 2024 | 184,000.00 |
| Jun 30, 2024 | 182,000.00 |
| Mar 31, 2024 | 186,000.00 |
| Dec 31, 2023 | 188,000.00 |
| Sep 30, 2023 | 178,000.00 |
| Jun 30, 2023 | 184,000.00 |
| Mar 31, 2023 | 189,000.00 |
| Dec 31, 2022 | 194,000.00 |
| Sep 30, 2022 | 193,000.00 |
| Jun 30, 2022 | 195,000.00 |
| Mar 31, 2022 | 199,000.00 |
| Dec 31, 2021 | 199,000.00 |
| Sep 30, 2021 | 199,000.00 |
| Jun 30, 2021 | 199,000.00 |